2005 Annual Session - Update in Endocrinology
American College of Physicians
American College of Physicians  
Home Topics Events Presenters Specials Help
Search:  

2008 Topics

Additional Topics
Associates, Residents and Fellows in Training
Cardiology
Career and Professionalism
Clinical Pearls
Computer in Practice
Clinical Pharmacology
Ethics and Health Policy
Endocrinology
Gastroenterology and Hepatology
Health Issues Related to Age and Gender
Hematology
Hospital Medicine
Infectious Diseases
Medical Practice Management
Multiple Small Feedings of the Mind
Nephrology and Hypertension
Neurology
Oncology
Ophthalmology and Otolaryngology
Perioperative Medicine
Pre-Session Courses
Psychiatry
Pulmonary Diseases and Critical Care
Rheumatology and Allergy & Immunology
Updates

2005 Annual Session


Update in Endocrinology

Session #: 855-148
Presenter(s): Leonard Wartofsky
Session Length: 1:30 hr
Event: 2005 ACP Annual Session
Date: April 14-16, 2005

Purchase Media - Session #: 855-148
Description Price Qty. Cart
 MP3 $17.00 buy now  
 CD $17.00 buy now  
 iPod Audio $17.00 buy now  

Clinical questions to be addressed:
REPRODUCTIVE HORMONES
Is Symptom Relief with HRT during menopause worth the risks?
Would growth hormone be an effective anabolic adjunct in HIV-infected men?
Is Sildenafil safe in men with congestive heart failure?
THYROID HORMONES
Do excesses of thyroid hormone increase miscarriage rates?
What are the risks to thyroid function in patients with Hepatitis C undergoing combination treatment with interferon alfa and ribavirin?
Does addition of triiodothyronine (T3) to levothyroxine (T4) therapy for hypothyroidism improve well-being and clinical responses?
Should æsubclinical hypothyroidismÆ be treated with levothyroxine?
ADRENAL HORMONES
Do corticosteroids improve outcomes in patients with septic shock?
Should we be distinguishing between true adrenal insufficiency in the ICU and reduced plasma cortisol secondary to protein binding changes?
Is there a linear relationship between serum aldosterone levels and risk of hypertension?
DIABETES MELLITUS
When should angiotensin receptor antagonists be started in hypertensive diabetics?
Is stress testing sufficient to detect myocardial ischemia in diabetics?
Should Diabetic Ketoacidosis (DKA) be managed in the ICU?
Can glycosylated hemoglobin levels serve as a predictor for cardiovascular disease (CVD) events ?
What are the newest and most novel approaches to diabetes management for the future?
LIPIDS
How effective are lipid lowering agents in diabetics?
How much should LDL be lowered to benefit coronary risk?
Does statin therapy promise benefit for stroke reduction as well as coronary disease reduction?
How much more efficacious is statin plus ezetimibe therapy than administration of a statin alone?
What endocrine problem other than hyperthyroidism is associated with atrial fibrillation ?




About     |   Contact Us   |   FAQ   |   Order Process   |   Privacy Policy   |   Shipping Policy   |   Your Account   |   Login   |   View Cart
© Copyright 2006 iPlayback. All Rights Reserved.
Developed in and hosted by CommerceV3.